News
STEM
10.80
0.00%
0.00
MICROBOT MEDICAL INC - CLINICAL TRIAL RESULTS TO BE PRESENTED AT MEDICAL CONFERENCE IN EARLY 2025
Reuters · 3d ago
MICROBOT MEDICAL ANNOUNCES THE SUCCESSFUL COMPLETION OF ITS PIVOTAL HUMAN CLINICAL TRIAL; ACCELERATES GO-TO-MARKET STRATEGY TO PREPARE FOR COMMERCIAL LAUNCH OF LIBERTY® DURING 2Q 2025
Reuters · 3d ago
MICROBOT MEDICAL ACCELERATES PATIENT ENROLLMENT OF ITS PIVOTAL HUMAN CLINICAL TRIAL; EXPECTS TO COMPLETE THE TRIAL EARLIER THAN ANTICIPATED AS 80% OF PATIENTS HAVE COMPLETED FOLLOW UP
Reuters · 09/30 12:30
MICROBOT MEDICAL INC - ON TRACK FOR FDA 510(K) SUBMISSION BY END OF 2024
Reuters · 09/30 12:30
MICROBOT MEDICAL INC - TO FILE 510(K) SUBMISSION WITH FDA BY YEAR-END
Reuters · 09/17 12:30
MICROBOT MEDICAL ANNOUNCES THE SUCCESSFUL ENROLLMENT OF 50% OF THE PATIENTS IN ITS PIVOTAL HUMAN CLINICAL TRIAL FOR THE LIBERTY ENDOVASCULAR ROBOTIC SURGICAL SYSTEM
Reuters · 09/17 12:30
MICROBOT MEDICAL SIGNS PHASE 2 COLLABORATION AGREEMENT WITH COREWELL HEALTH TO ADVANCE REMOTE TELESURGERY USING THE LIBERTY® ENDOVASCULAR ROBOTIC SYSTEM
Reuters · 08/22 12:30
Microbot Medical Inc reports results for the quarter ended in June - Earnings Summary
Reuters · 08/15 12:05
MICROBOT MEDICAL COMPLETES THE ENROLLMENT OF CLINICAL SITES IN ITS PIVOTAL HUMAN CLINICAL TRIAL WITH THE ADDITION OF MEMORIAL SLOAN KETTERING CANCER CENTER
Reuters · 07/18 12:30
MICROBOT MEDICAL CONTINUES TO RAMP UP PATIENT ENROLLMENT IN ITS PIVOTAL HUMAN CLINICAL TRIAL
Reuters · 07/09 12:30
MICROBOT MEDICAL ENROLLED THE FIRST PATIENT IN ITS PIVOTAL HUMAN CLINICAL TRIAL
Reuters · 07/08 12:20
MICROBOT MEDICAL PARTNERS WITH BRIGHAM AND WOMEN'S HOSPITAL FOR ITS PIVOTAL HUMAN CLINICAL TRIAL
Reuters · 06/20 12:25
MICROBOT MEDICAL ANNOUNCES BRIGHAM AND WOMEN'S HOSPITAL AS A SITE FOR ITS PIVOTAL HUMAN CLINICAL TRIAL
Reuters · 06/17 12:30
MICROBOT MEDICAL-FILES PROSPECTUS RELATES TO SALE FROM TIME TO TIME OF UP TO 3.2 MLN SHARES OF COMMON STOCK BY SELLING STOCKHOLDERS
Reuters · 06/11 17:17
MICROBOT MEDICAL ANNOUNCES CLOSING OF $2.35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Reuters · 06/04 20:20
MICROBOT MEDICAL ANNOUNCES $2.35 MILLION REGISTERED DIRECT OFFERING PRICED AT-THE-MARKET UNDER NASDAQ RULES
Reuters · 06/03 16:11
MICROBOT MEDICAL HAS RECEIVED FDA APPROVAL TO PROCEED WITH ITS PIVOTAL HUMAN CLINICAL TRIAL
Reuters · 06/03 12:20
MICROBOT MEDICAL ANNOUNCES POSITIVE RESULTS FROM THE FIRST PHASE OF ITS COLLABORATION WITH COREWELL HEALTH™
Reuters · 04/29 12:30
MICROBOT MEDICAL - SEES RECEIVING 510(K) CLEARANCE FROM US FOOD & DRUG ADMINISTRATION IN THE FIRST HALF OF 2025, AND CE MARK APPROVAL IN H2 OF 2025
Reuters · 04/24 20:56
MICROBOT MEDICAL, INC. <MBOT.O>: H.C. WAINWRIGHT CUTS TARGET PRICE TO $7 FROM $8
Reuters · 04/16 11:21
More
Webull provides a variety of real-time STEM stock news. You can receive the latest news about Microbot Medical through multiple platforms. This information may help you make smarter investment decisions.
About STEM
Microbot Medical Inc. is a pre-clinical medical device company. The Company is focused on the research, design and development of robotic endoluminal surgery devices targeting the minimally invasive surgery space. Its technological platforms, ViRob, TipCAT and Liberty, including certain CardioSert assets, are comprised of proprietary technologies. Using the ViRob platform, Microbot is developing the Self Cleaning Shunt (SCSTM) for the treatment of hydrocephalus and Normal Pressure Hydrocephalus (NPH). Utilizing the Liberty and CardioSert platforms, it is developing disposable robot for various endovascular interventional procedures. ViRob technology is an autonomous crawling micro-robot. TipCAT is a disposable self-propelled locomotive device. Liberty is a disposable robotic system.